Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Iqvia Holdings Inc.
  6. News
  7. Summary
    IQV   US46266C1053

IQVIA HOLDINGS INC.

(IQV)
  Report
Delayed Nyse  -  04:03 2022-08-17 pm EDT
240.62 USD   -1.67%
08/15IQVIA Wins Snowflake's “Marketplace Healthcare and Life Sciences Partner of the Year” Award
BU
08/11Cipher Pharmaceuticals Reports Q2 Diluted EPS of US$0.08
MT
08/08GlaxoSmithKline, IQVIA Introduce Vaccination Data Tracker
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Piper Sandler Lifts IQVIA Holdings to Overweight From Neutral, Price Target to $255 From $231

04/29/2022 | 05:30am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
All news about IQVIA HOLDINGS INC.
08/15IQVIA Wins Snowflake's “Marketplace Healthcare and Life Sciences Partner of the Y..
BU
08/11Cipher Pharmaceuticals Reports Q2 Diluted EPS of US$0.08
MT
08/08GlaxoSmithKline, IQVIA Introduce Vaccination Data Tracker
MT
07/29IQVIA HOLDINGS INC. : Change in Directors or Principal Officers (form 8-K)
AQ
07/29IQVIA Holdings Inc. Announces Executive Changes
CI
07/27Dr. Reddy's Launches Generic Version of Myeloma Drug Velcade in US
MT
07/26China Accepts Sihuan Pharmaceutical Unit's Marketing for Breast Cancer Injection
MT
07/22IQVIA HOLDINGS INC. Management's Discussion and Analysis of Financial Condition and Re..
AQ
07/22Barclays Adjusts Price Target on IQVIA Holdings to $255 from $236, Keeps Overweight Rat..
MT
07/22Morgan Stanley Adjusts IQVIA Holdings' Price Target to $260 from $255, Keeps Overweight..
MT
More news
Analyst Recommendations on IQVIA HOLDINGS INC.
More recommendations
Financials (USD)
Sales 2022 14 500 M - -
Net income 2022 1 221 M - -
Net Debt 2022 10 874 M - -
P/E ratio 2022 38,3x
Yield 2022 -
Capitalization 45 640 M 45 640 M -
EV / Sales 2022 3,90x
EV / Sales 2023 3,54x
Nbr of Employees 83 000
Free-Float 72,2%
Chart IQVIA HOLDINGS INC.
Duration : Period :
Iqvia Holdings Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IQVIA HOLDINGS INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 20
Last Close Price 244,71 $
Average target price 267,72 $
Spread / Average Target 9,40%
EPS Revisions
Managers and Directors
Ari Bousbib Chairman, President & Chief Executive Officer
Ronald Earl Bruehlman Chief Financial Officer & Executive Vice President
Karl Guenault Chief Information Officer & Senior Vice President
Jeffrey A. Spaeder Chief Medical & Scientific Officer
Costa Panagos President-Research & Development Solutions
Sector and Competitors
1st jan.Capi. (M$)
IQVIA HOLDINGS INC.-13.27%45 640
MODERNA, INC.-33.87%65 706
LONZA GROUP AG-26.68%43 587
SEAGEN INC.10.30%31 450
ALNYLAM PHARMACEUTICALS, INC.34.54%27 384
CELLTRION, INC.7.07%22 159